Core Scientific, Inc./tx (CORZZ)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 300M 600M 900M Q4 '21: 544.5M Q1 '22: 682.8M Q2 '22: 771.4M Q3 '22: 820.9M Q4 '22: 640.3M Q1 '23: 568.4M Q2 '23: 531.4M Q3 '23: 481.7M Q4 '23: 502.4M Q1 '24: 561M Q2 '24: 575.2M Q3 '24: 557.7M Q4 '24: 510.7M Q1 '25: 410.9M Q2 '25: 348.4M Q3 '25: 334.2M Q4 '25: 319M Q1 '26: 354.7M Q2 '26: 440.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

-150M 0 150M 300M 450M Q4 '21: 238.9M Q1 '22: 294.3M Q2 '22: 282.5M Q3 '22: 197M Q4 '22: 8.4M Q1 '23: -29.8M Q2 '23: -5.6M Q3 '23: 36.9M Q4 '23: 123.5M Q1 '24: 169.3M Q2 '24: 171.2M Q3 '24: 155.6M Q4 '24: 121.1M Q1 '25: 51.6M Q2 '25: 17.8M Q3 '25: 21.9M Q4 '25: 37.9M Q1 '26: 59.8M Q2 '26: 124.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income TTM

-2.4B -1.6B -800M 0 800M 1.6B 2.4B Q4 '21: 131.5M Q1 '22: 95.8M Q2 '22: -965.2M Q3 '22: -1.4B Q4 '22: -2.1B Q1 '23: -2.1B Q2 '23: -1B Q3 '23: -631.1M Q4 '23: 9M Q1 '24: 56.6M Q2 '24: -43.6M Q3 '24: -72.7M Q4 '24: -142.1M Q1 '25: -244.3M Q2 '25: -179.9M Q3 '25: -193.5M Q4 '25: -245.6M Q1 '26: -509M Q2 '26: -561.2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-2.4B -1.6B -800M 0 800M 1.6B 2.4B Q4 '21: 47.3M Q1 '22: -425.7M Q2 '22: -1.2B Q3 '22: -1.7B Q4 '22: -2.1B Q1 '23: -1.7B Q2 '23: -879.3M Q3 '23: -485.6M Q4 '23: -246.5M Q1 '24: -35.4M Q2 '24: -928.3M Q3 '24: -1.3B Q4 '24: -1.4B Q1 '25: -1.1B Q2 '25: -1.1B Q3 '25: -795.7M Q4 '25: -288.6M Q1 '26: -1.2B Q2 '26: -1.4B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 250M 500M 750M Q4 '21: 305.6M Q1 '22: 388.4M Q2 '22: 488.9M Q3 '22: 623.8M Q4 '22: 631.9M Q1 '23: 598.3M Q2 '23: 537M Q3 '23: 444.8M Q4 '23: 378.9M Q1 '24: 391.7M Q2 '24: 404M Q3 '24: 402.1M Q4 '24: 389.6M Q1 '25: 359.3M Q2 '25: 330.6M Q3 '25: 312.3M Q4 '25: 281.1M Q1 '26: 294.9M Q2 '26: 315.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

-200M 0 200M 400M 600M Q4 '21: -56.7M Q1 '22: -75.8M Q2 '22: 205.9M Q3 '22: 198.9M Q4 '22: 205.2M Q1 '23: 228.7M Q2 '23: 101.9M Q3 '23: 159.4M Q4 '23: 65.1M Q1 '24: 67.3M Q2 '24: 50.5M Q3 '24: 50.8M Q4 '24: 42.9M Q1 '25: -24.3M Q2 '25: 8.5M Q3 '25: 134.5M Q4 '25: 278.2M Q1 '26: 573.2M Q2 '26: 520.2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

-1.1B -700M -350M 0 350M 700M 1.1B Q4 '22: -178.8M Q1 '23: -23.6M Q2 '23: -45.3M Q3 '23: 14.7M Q4 '23: 49M Q1 '24: 20.8M Q2 '24: 1.1M Q3 '24: -27.1M Q4 '24: -52.1M Q1 '25: -171.4M Q2 '25: -256.7M Q3 '25: -344M Q4 '25: -450.8M Q1 '26: -461.1M Q2 '26: -957.7M Q4 '22 Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 150M 300M 450M Q1 '21: 176M Q2 '21: 158.9M Q3 '21: 237M Q1 '22: 307.5M Q2 '22: 325M Q3 '22: 354.2M Q1 '23: 375.4M Q2 '23: 375.8M Q3 '23: 382.5M Q1 '24: 282.5M Q2 '24: 178.5M Q3 '24: 292.5M Q1 '25: 363.3M Q2 '25: 318M Q3 '25: 318.6M Q1 '26: 322.9M Q2 '26: 325.3M Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-7.50 -5.00 -2.50 0.00 2.50 5.00 7.50 Q4 '21: 0.22 Q1 '22: -1.34 Q2 '22: -3.81 Q3 '22: -4.97 Q4 '22: -6.16 Q1 '23: -4.64 Q2 '23: -2.17 Q3 '23: -1.05 Q4 '23: -0.65 Q1 '24: 0.13 Q2 '24: -4.90 Q3 '24: -5.96 Q4 '24: -6.13 Q1 '25: -5.67 Q2 '26: -6.46 Q4 '21 Q2 '22 Q4 '22 Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.